CANADIAN ANIMAL HEALTH INSTITUTE (CAHI) / Institut canadien de la santé animale (ICSA)
Registration:
11
of
38
(2003-08-06
to
2004-02-09)
Subject Matter: Retrospective:
|
VETERINARY DRUGS DIRECTORATE (VDD) - HEALTH CANADA: CAHI HAS LOBBIED FOR CHANGE TO THE REGULATORY PROCESS FOR APPROVAL OF NEW ANIMAL PHARMACEUTICAL PRODUCTS. WE MAY ALSO MEET WITH TREASURY BOARD ON THIS ISSUE.NON-APPROVED ANIMAL HEALTH PRODUCTS: ACTIVELY PURSUING THE ESTABLISHMENT OF A COMPLIANCE AND SURVEILLANCE PROGRAM FOR ANIMAL PHARMACEUTICALS. CAHI HAS HAD INTERVENTION WITH POLITICIANS, POLITICAL ASSISTANTS AND/OR BUREAUCRATS WITH THE FEDERAL DEPARTMENTS OF AGRICULTURE, HEALTH, TREASURY BOARD AND TRADE.GOOD MANUFACTURING PRACTICES (GMPS): DEVELOPMENT OF VETERINARY DRUG ANNEX TO THE GMP REGULATIONS.ADVERTISING OF PRESCRIPTION DRUGS FOR ANIMAL USE: CAHI HAS PROPOSED RECOMMENDATIONS TO CHANGE THE EXISTING ADVERTISING REGULATIONS UPON REQUEST BY VDD FOR STAKEHOLDER REVIEW AND INPUT.EXTRA LABEL USE: CAHI HAS PROPOSED SUGGESTIONS TO THE VDD FOR ACHIEVING THE MOST EFFECTIVE RESPONSES TO THEIR PROPOSED EXTRA LABEL USE STUDY OF ANIMAL HEALTH MEDICATIONS IN CANADA.VETERINARY BIOLOGICS SECTION OF THE CANADIAN FOOD INSPECTION AGENCY: CAHI MAY INTERACT WITH MEMBERS OF THIS SECTION ON AN AS-NEEDED BASIS.
|
Subject Matter: Prospective:
|
WE WILL CONTINUE TO LOBBY ON THE SAME ISSUES NOTED ABOVE.
|